首页 › 基金 › Sofinnova Investments, Inc. › GMED
Sofinnova Investments, Inc. 对 GMED 的持仓历史
GLOBUS MED INC · 医疗保健
Sofinnova Investments, Inc. 在 Q2 2026 的 13F 申报中披露持有 GMED(GLOBUS MED INC)200,000 股,市值约 US$15.8M,约占其申报组合的 0.84%,在其申报持仓中市值排名第 31 位。 Sofinnova Investments, Inc. 最近 7 个申报季度中有 2 个季度披露了 GMED 持仓,最早可追溯至 Q4 2024。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Sofinnova Investments, Inc. 对 GMED 的持仓演变
Sofinnova Investments, Inc. 于 Q4 2024 首次披露 GMED 持仓:244,700 股(约 US$20.2M)。 在 2 次申报中,Sofinnova Investments, Inc. 的持股数量始终未变。 最近一期申报(Q2 2026)显示持股 200,000 股、市值约 US$15.8M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2024 | 244.70K | $20.24M | 新进 |
| Q2 2026 | 200.00K | $15.80M | 新进 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 GMED 与 13F 数据
GMED(GLOBUS MED INC)属于医疗保健行业。我们追踪的基金中还有 39 只申报持有 GMED,申报仓位最大的包括:KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (US$338.1M), Sculptor Capital LP (US$237.0M), Boston Trust Walden Corp (US$124.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 GMED 的基金
- KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 4.28M 股 · $338.14M · Q2 2026
- Sculptor Capital LP 3.00M 股 · $237.03M · Q2 2026
- Boston Trust Walden Corp 1.57M 股 · $124.31M · Q2 2026
- GW&K Investment Management, LLC 1.45M 股 · $114.82M · Q2 2026
- GENEVA CAPITAL MANAGEMENT LLC 1.42M 股 · $111.96M · Q2 2026
- Madison Avenue Partners, LP 935.22K 股 · $73.89M · Q2 2026
- ANTIPODES PARTNERS Ltd 905.98K 股 · $71.58M · Q2 2026
- PARADIGM CAPITAL MANAGEMENT INC/NY 886.50K 股 · $70.04M · Q2 2026
更多关于 Sofinnova Investments, Inc.
常见问题
How long has Sofinnova Investments, Inc. held GMED?
Sofinnova Investments, Inc. has disclosed GMED holdings in 2 of the last 7 reported quarters, going back to Q4 2024.
What is Sofinnova Investments, Inc.'s current position in GMED?
As of Q2 2026, Sofinnova Investments, Inc. holds 200.00K shares of GMED (GLOBUS MED INC), valued at $15.80M, representing 0.84% of its reported portfolio and ranking #31.
Has Sofinnova Investments, Inc. been buying or selling GMED?
In the latest 13F filing (Q2 2026), Sofinnova Investments, Inc. newly opened its position in GMED.
Which other funds hold GMED?
Other major institutional holders of GMED include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, Sculptor Capital LP, Boston Trust Walden Corp, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.